Meyka Pro banner
Jiangxi Rimag Group Co., Ltd.

Jiangxi Rimag Group Co., Ltd. (HKSE: 2522.HK) AI-Powered Stock Analysis

See how Jiangxi Rimag Group Co., Ltd. scores across key metrics like financial growth, valuation, and market position on the HKSE, using AI-driven evaluation.

2522.HKHKSE
HealthcareMedical - Care Facilities
HK$4.97
HK$0.03(0.61%)
Hong Kong Market opens in 22h 32m

Jiangxi Rimag Group Co., Ltd. (HKSE: 2522.HK) AI-Powered Stock Analysis

See how Jiangxi Rimag Group Co., Ltd. scores across key metrics like financial growth, valuation, and market position on the HKSE, using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full Disclaimer

Jiangxi Rimag Group Co., Ltd. (HKSE: 2522.HK) Stock Overall Grade

Jiangxi Rimag Group Co., Ltd.'s grade for its HKSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

Z

Grade Breakdown by Metric

See how each financial and market factor contributes to Jiangxi Rimag Group Co., Ltd.'s overall HKSE stock rating.

Forecast

C+

Score

58/100

Financial Growth

C

Score

40/100

Fundamental Growth

C

Score

47/100

Key Ratios

B

Score

64/100

Sector Comparison

B+

Score

75/100

Industry Comparison

C+

Score

50/100

S&P 500 Benchmark

A+

Score

97/100

Analyst Consensus

C+

Score

50/100

Jiangxi Rimag Group Co., Ltd. (HKSE: 2522.HK) AI-Powered Stock Analysis

On the HKSE, 2522.HK demonstrates Good performance with an overall Forecast Score of 58/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (47/100, C) highlight its stability, while Key Ratios (64/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the HKSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.

(HKSE: 2522.HK) Component Analysis Explained

Understand the key factors behind each Jiangxi Rimag Group Co., Ltd. (HKSE: 2522.HK) stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions